“There is currently no standard of care for anticoagulation in hospitalized COVID-19 patients, and there is a desperate need for clinical evidence to guide practice,” one NIH official said. 

Wildfires continue to burn throughout the Western United States, making it harder than ever for patients and providers in those areas to deal with the ongoing pandemic. 

After athletes recover from COVID-19, when can they get back to their regular schedules? CMR imaging seems as if it will play a key role when it comes to making such decisions. 

The role of ACE inhibitors and ARBs in the treatment of COVID-19 has been a key topic for researchers since the pandemic began. This latest research represents a significant update for clinicians. 

The emerging academic discipline of social data science, which leverages Big Data to integrate social science with computer science, has a new base of operations in the Mid-Atlantic region.  

The combination of inflammation and thrombosis is crucial, suggesting that endothelial dysfunction could be at the heart of this complex infection.

During a 12-week peak in the COVID-19 crisis, an 800-bed academic hospital in a frenetic American city admitted more than 9,000 inpatients—including almost 700 with COVID—while letting only two infections sneak in unchecked. 

Researchers focused on long-term heart and lung damage among recovered COVID-19 patients, turning to lung function tests, CT imaging and echocardiograms.